SOX2 and lung carcinoma: Further, we observed an increase in the induced co‐expression pattern of the SOX2‐OT with SOX2 (Fig. 2A) after treatment with cisplatin or TKI‐erlotinib at 48 and 120 h in lung cancer cells A549 (Fig. 2C).